IMO, if leronlimab is proven to treat a wide varie
Post# of 148300
(Total Views: 696)
Posted On: 12/11/2019 3:42:59 PM
Re: craigakess #12489
IMO, if leronlimab is proven to treat a wide variety of metastatic cancers, then the price for the drug can and will be reasonably priced because there will be a broad demand for it. This is in contrast to a drug developed and approved for a disease with only a few hundred or few thousand patients, which may be priced in the 6-7 figure range.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼